These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36793206)

  • 1. Basiliximab induction versus no induction in adult heart transplantation.
    Rudzik KN; Rivosecchi RM; Palmer BA; Hickey GW; Huston JH; Keebler ME; Kaczorowski DJ; Horn ET
    Clin Transplant; 2023 May; 37(5):e14937. PubMed ID: 36793206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of induction strategy change on first-year rejection in pediatric heart transplantation at a single center-From postoperative basiliximab to either postoperative anti-thymocyte globulin or preoperative basiliximab.
    Sisson TM; Padilla LA; Hubbard M; Smith S; Pearce FB; Collins JL; Carlo WF
    Clin Transplant; 2021 Jun; 35(6):e14314. PubMed ID: 33838071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basiliximab as maintenance immunosuppression in heart transplant recipients: A single pediatric center experience.
    Chen TT; Greene MM; Everitt MD; Simpson KE
    Pediatr Transplant; 2023 Mar; 27(2):e14438. PubMed ID: 36397270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab.
    Ansari D; Lund LH; Stehlik J; Andersson B; Höglund P; Edwards L; Nilsson J
    J Heart Lung Transplant; 2015 Oct; 34(10):1283-91. PubMed ID: 26087667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A heart transplant center experience with basiliximab induction strategies: A double edged sword?
    Holzhauser L; Norris M; Molina M; Chambers S; Sundaravel S; Rashed E; Gala K; Fallah T; Bittermann T; Reza N; Wang T; Atluri P; Goldberg L; McLean R; Peyster E
    Clin Transplant; 2024 Apr; 38(4):e15307. PubMed ID: 38567897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basiliximab and heart transplantation in Hispanics: the experience in Puerto Rico.
    Banchs HL; Carro Jiménez EJ; González V; González Cancel IF; Quintana C; Calderón R; Altieri PI; Rivera C
    Bol Asoc Med P R; 2007; 99(3):191-6. PubMed ID: 19610574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation.
    Flaman F; Zieroth S; Rao V; Ross H; Delgado DH
    J Heart Lung Transplant; 2006 Nov; 25(11):1358-62. PubMed ID: 17097501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basiliximab: a review of its use as induction therapy in renal transplantation.
    Chapman TM; Keating GM
    Drugs; 2003; 63(24):2803-35. PubMed ID: 14664658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of immunosuppression induction with basiliximab compared to antithymocyte-globulin in adult heart transplant patients.
    Eberhardt TE; Kim DH; Nethersole S; Pearson GJ
    Clin Transplant; 2024 Jun; 38(6):e15332. PubMed ID: 38804609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of single-dose anti-thymocyte globulin versus basiliximab induction therapy in pediatric kidney transplant recipients: A retrospective comparative cohort study.
    Custodio LFP; Martins SBS; Viana LA; Cristelli MP; Requião-Moura L; Chow CYZ; Camargo SFDN; Nakamura MR; Foresto RD; Tedesco-Silva H; Medina-Pestana J
    Pediatr Transplant; 2024 May; 28(3):e14713. PubMed ID: 38553819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive T-cell antibody induction for heart transplant recipients.
    Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008842. PubMed ID: 24297433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective comparison of the efficacy and safety in kidney transplant recipients with basiliximab and anti-thymocyte globulin.
    Wang W; Yin H; Li XB; Hu XP; Yang XY; Liu H; Ren L; Wang Y; Zhang XD
    Chin Med J (Engl); 2012 Mar; 125(6):1135-40. PubMed ID: 22613543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation Recipients.
    Furuya Y; Jayarajan SN; Taghavi S; Cordova FC; Patel N; Shiose A; Leotta E; Criner GJ; Guy TS; Wheatley GH; Kaiser LR; Toyoda Y
    Am J Transplant; 2016 Aug; 16(8):2334-41. PubMed ID: 26833657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of basiliximab vs antithymocyte globulin for induction in pediatric heart transplant recipients: An analysis of the International Society for Heart and Lung Transplantation database.
    Butts RJ; Dipchand AI; Sutcliffe D; Bano M; Dimas V; Morrow R; Das B; Kirk R
    Pediatr Transplant; 2018 Jun; 22(4):e13190. PubMed ID: 29878688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction immunosuppression strategies and long-term outcomes after heart transplantation.
    Nozohoor S; Stehlik J; Lund LH; Ansari D; Andersson B; Nilsson J
    Clin Transplant; 2020 Jul; 34(7):e13871. PubMed ID: 32271484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy.
    Mattei MF; Redonnet M; Gandjbakhch I; Bandini AM; Billes A; Epailly E; Guillemain R; Lelong B; Pol A; Treilhaud M; Vermes E; Dorent R; Lemay D; Blanc AS; Boissonnat P
    J Heart Lung Transplant; 2007 Jul; 26(7):693-9. PubMed ID: 17613399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
    ; Haynes R; Harden P; Judge P; Blackwell L; Emberson J; Landray MJ; Baigent C; Friend PJ
    Lancet; 2014 Nov; 384(9955):1684-90. PubMed ID: 25078310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.
    Thomusch O; Wiesener M; Opgenoorth M; Pascher A; Woitas RP; Witzke O; Jaenigen B; Rentsch M; Wolters H; Rath T; Cingöz T; Benck U; Banas B; Hugo C
    Lancet; 2016 Dec; 388(10063):3006-3016. PubMed ID: 27871759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of economic benefit with basiliximab induction in living related donor adult renal transplant recipients.
    Crompton JA; Somerville T; Smith L; Corbett J; Nelson E; Holman J; Shihab FS
    Pharmacotherapy; 2003 Apr; 23(4):443-50. PubMed ID: 12680474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of induction therapy on cytomegalovirus infection and post-transplant outcomes in pediatric heart transplant recipients receiving routine antiviral prophylaxis.
    Zang S; Zhang X; Niu J; Das BB
    Clin Transplant; 2023 Jan; 37(1):e14836. PubMed ID: 36259556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.